BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Emma Rose McGlone, Ahmed R. Ahmed. Global Bariatric Surgery2018; : 403 doi: 10.1007/978-3-319-93545-4_36
2
Shui-Xian Du, Lin-Lin Lu, Yang Liu, Quan-Jiang Dong, Shi-Ying Xuan, Yong-Ning Xin. Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.37388
3
Hui Li, Mark J. Canet, John D. Clarke, Dean Billheimer, Stavra A. Xanthakos, Joel E. Lavine, Robert P. Erickson, Nathan J. Cherrington. Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic SteatohepatitisDrug Metabolism and Disposition 2017; 45(12): 1317 doi: 10.1124/dmd.117.077644
4
George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou, George K. Koukoulis. NAFLD and autoimmune hepatitis: Do not judge a book by its coverEuropean Journal of Internal Medicine 2020; 75: 1 doi: 10.1016/j.ejim.2020.02.001
5
Lorena Bavia, Bruno Cogliati, Juliano Bertollo Dettoni, Venancio Avancini Ferreira Alves, Lourdes Isaac. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease modelImmunology Letters 2016; 177: 53 doi: 10.1016/j.imlet.2016.07.014
6
Cemal Nuri Ercin, Teoman Dogru, Halil Genc, Gurkan Celebi, Fatih Aslan, Hasan Gurel, Muammer Kara, Erdim Sertoglu, Serkan Tapan, Sait Bagci, Manfredi Rizzo, Alper Sonmez. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver DiseaseMetabolic Syndrome and Related Disorders 2015; 13(7): 319 doi: 10.1089/met.2015.0018
7
Shigeru Murakami, Ayuko Ono, Azusa Kawasaki, Takaaki Takenaga, Takashi Ito. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitroAmino Acids 2018; 50(9): 1279 doi: 10.1007/s00726-018-2605-8
8
Sumit Kar, Sabina Paglialunga, Sharon H. Jaycox, Rafiqul Islam, Angelo H. Paredes, Rohit Kohli. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosisPLOS ONE 2019; 14(7): e0217263 doi: 10.1371/journal.pone.0217263
9
Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver diseaseInflammation Research 2020; 69(9): 851 doi: 10.1007/s00011-020-01373-7
10
Karen R. Jonscher, Robert B. Rucker. Dietary Interventions in Liver Disease2019; : 157 doi: 10.1016/B978-0-12-814466-4.00013-6
11
Silvano Junior Santini, Cristiana Porcu, Giovanni Tarantino, Fernanda Amicarelli, Clara Balsano. Oleuropein overrides liver damage in steatotic miceJournal of Functional Foods 2020; 65: 103756 doi: 10.1016/j.jff.2019.103756
12
Nadia Panera, Claudia Della Corte, Annalisa Crudele, Laura Stronati, Valerio Nobili, Anna Alisi. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokinesExpert Review of Gastroenterology & Hepatology 2016; 10(3): 393 doi: 10.1586/17474124.2016.1110485
13
Sifan Chen, Zhongliang Zhao, Liangru Ke, Zilun Li, Wenxue Li, Zili Zhang, Ying Zhou, Xiang Feng, Wei Zhu. Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1The Journal of Nutritional Biochemistry 2018; 55: 209 doi: 10.1016/j.jnutbio.2018.02.007
14
Marko Duvnjak, Sanja Stojsavljević, Lucija Virović Jukić, Lea Smirčić Duvnjak. Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLDJournal of Clinical and Translational Hepatology 2019; 7(2): 97 doi: 10.14218/JCTH.2019.00022
15
Noha El Nakeeb, Shereen A Saleh, Yasmine M Massoud, Ahmed Hussein, Rana Hamed. Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver diseaseJGH Open 2017; 1(3): 112 doi: 10.1002/jgh3.12019
16
Antonio Olveira, Pedro Herranz, María Luisa Montes. Psoriasis and fatty liver: a harmful synergyRevista Española de Enfermedades Digestivas 2019; 111: 314 doi: 10.17235/reed.2019.6263/2019
17
Simona Cernea, Andrada Larisa Roiban, Emőke Both, Adina Huţanu. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetesDiabetes/Metabolism Research and Reviews 2018; 34(8): e3050 doi: 10.1002/dmrr.3050
18
Ai‐rong Zhang, Jing Sun, Yuan He, Ning Wang, Li Tian. Attenuation of lipid accumulation in Bel‐7402 cells through ADPN/AMPKα signaling stimulated by Fructus rosae laxae extractJournal of Food Biochemistry 2020;  doi: 10.1111/jfbc.13497
19
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting I κ B α Degradation in Mice Hepatology 2018; 68(5): 1769 doi: 10.1002/hep.30066
20
Claudia Calder�n‑Torres, Lirio Sarabia‑Curz, Yadira Ledesma‑Soto, Miguel Murgu�a‑Romero, Luis Terrazas‑Vald�s. Denitrase activity of Debaryomyces�hansenii reduces the oxidized compound 3‑nitrotyrosine in mice liver with colitisExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7395
21
Abdelghany Hassan Abdelghany, Mohammad A. BaSalamah, Shakir Idris, Jawwad Ahmad, Bassem Refaat. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in ratsJournal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1040-4
22
Rohith N. Thota, Jessica J. A. Ferguson, Kylie A. Abbott, Cintia B. Dias, Manohar L. Garg. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effectsvs. clinical outcomesFood & Function 2018; 9(7): 3576 doi: 10.1039/C8FO00348C
23
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
24
Doaa El Amrousy, Dalia El-Afify. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver diseaseCytokine 2020; 135: 155215 doi: 10.1016/j.cyto.2020.155215
25
Hong Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao, Li-Na Xu, Lian-Hong Yin, Yan Qi, Jin-Yong Peng. Herbal medicines and nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(30): 6890-6905 doi: 10.3748/wjg.v22.i30.6890
26
Smitha Krishnan, Yufang Ding, Nima Saedi, Maria Choi, Gautham V. Sridharan, David H. Sherr, Martin L. Yarmush, Robert C. Alaniz, Arul Jayaraman, Kyongbum Lee. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and MacrophagesCell Reports 2018; 23(4): 1099 doi: 10.1016/j.celrep.2018.03.109
27
Jun-Qi Shi, Wen-Xia Shen, Xiang-Zhi Wang, Ke Huang, Chao-Chun Zou. Relationship between immune parameters and non-alcoholic fatty liver disease in obese childrenIndian Pediatrics 2017; 54(10): 825 doi: 10.1007/s13312-017-1143-x
28
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
29
Aoife N. O’Donovan, Florence M. Herisson, Fiona Fouhy, Paul M. Ryan, Derek Whelan, Crystal N. Johnson, Gaston Cluzel, R. Paul Ross, Catherine Stanton, Noel M. Caplice. Gut microbiome of a porcine model of metabolic syndrome and HF-pEFAmerican Journal of Physiology-Heart and Circulatory Physiology 2020; 318(3): H590 doi: 10.1152/ajpheart.00512.2019
30
Madeleine Themanns, Kristina M. Mueller, Sonja M. Kessler, Nicole Golob-Schwarzl, Thomas Mohr, Doris Kaltenecker, Jerome Bourgeais, Jamile Paier-Pourani, Katrin Friedbichler, Doris Schneller, Michaela Schlederer, Eva Zebedin-Brandl, Luigi M. Terracciano, Xiaonan Han, Lukas Kenner, Kay-Uwe Wagner, Wolfgang Mikulits, Andrey V. Kozlov, Markus H. Heim, Fabrice Gouilleux, Johannes Haybaeck, Richard Moriggl. Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in MiceScientific Reports 2016; 6(1) doi: 10.1038/srep34719
31
Adriano Lama, Claudio Pirozzi, Maria Pia Mollica, Giovanna Trinchese, Francesca Di Guida, Gina Cavaliere, Antonio Calignano, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli. Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed ratsMolecular Nutrition & Food Research 2017; 61(3): 1600418 doi: 10.1002/mnfr.201600418
32
Jennifer C Price, Ruibin Wang, Eric C Seaberg, Matthew J Budoff, Lawrence A Kingsley, Frank J Palella , Mallory D Witt, Wendy S Post, Chloe L Thio. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus SerostatusOpen Forum Infectious Diseases 2017; 4(3) doi: 10.1093/ofid/ofx153
33
Frédéric Hérault, Magalie Houée-Bigot, Elisabeth Baéza, Olivier Bouchez, Diane Esquerré, Christophe Klopp, Christian Diot. RNA-seq analysis of hepatic gene expression of common Pekin, Muscovy, mule and hinny ducks fed ad libitum or overfedBMC Genomics 2019; 20(1) doi: 10.1186/s12864-018-5415-1
34
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention StudyJournal of Medicinal Food 2019; 22(7): 729 doi: 10.1089/jmf.2018.0020
35
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse ModelPLOS ONE 2016; 11(5): e0154676 doi: 10.1371/journal.pone.0154676
36
Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Słabczyńska, Martyna Kandefer-Szerszeń, Patricia Aspichueta. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha KetoglutaratePLOS ONE 2015; 10(12): e0143851 doi: 10.1371/journal.pone.0143851
37
Keke Lu, Jing Wang, Yueyuan Yu, Yikuan Wu, Zhao He. Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in miceFood Science & Nutrition 2020; 8(6): 2588 doi: 10.1002/fsn3.1445
38
Xiaojing Wang, Lan Li, Hongwu Wang, Fang Xiao, Qin Ning. Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in miceScandinavian Journal of Immunology 2019; 90(3) doi: 10.1111/sji.12791
39
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive reviewWorld Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
40
Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathwayInternational Immunopharmacology 2016; 38: 377 doi: 10.1016/j.intimp.2016.06.023
41
Helena A.P. Batatinha, Edson A. Lima, Alexandre A.S. Teixeira, Camila O. Souza, Luana A. Biondo, Loreana S. Silveira, Fabio S. Lira, José C. Rosa Neto. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout MiceJournal of Cellular Physiology 2017; 232(5): 1008 doi: 10.1002/jcp.25440
42
Ji-Young Cha, Da-Hyun Kim, Kyung-Hee Chun. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisLaboratory Animal Research 2018; 34(4): 133 doi: 10.5625/lar.2018.34.4.133
43
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?Current HIV/AIDS Reports 2018; 15(3): 212 doi: 10.1007/s11904-018-0392-1
44
Mei-Jou Chen, Hong-Nerng Ho. Hepatic manifestations of women with polycystic ovary syndromeBest Practice & Research Clinical Obstetrics & Gynaecology 2016; 37: 119 doi: 10.1016/j.bpobgyn.2016.03.003
45
Shuangpeng Cai, Xiaoyu Cheng, Xueyin Pan, Jun Li. Emerging role of exosomes in liver physiology and pathologyHepatology Research 2017; 47(2): 194 doi: 10.1111/hepr.12794
46
Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseHepatology Communications 2018; 2(11): 1344 doi: 10.1002/hep4.1237
47
Jae B. Park, Renee Peters, Quynhchi Pham, Thomas T. Y. Wang. Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like CellsBiomedicines 2020; 8(6): 138 doi: 10.3390/biomedicines8060138
48
Cheng-Chung Li, Chun Liu, Maobin Fu, Kang-Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang-Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in MiceMolecular Nutrition & Food Research 2018; 62(8): 1700738 doi: 10.1002/mnfr.201700738
49
Silvia M. Ferolla. Obesity2016; : 159 doi: 10.1007/978-3-319-19821-7_13
50
Hee Jae Lee, Yunsook Lim, Soo Jin Yang. Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitroThe Journal of Nutritional Biochemistry 2015; 26(11): 1254 doi: 10.1016/j.jnutbio.2015.06.001
51
Shabir Hassan, Shikha Sebastian, Sushila Maharjan, Ami Lesha, Anne‐Marie Carpenter, Xiuli Liu, Xin Xie, Carol Livermore, Yu Shrike Zhang, Ali Zarrinpar. Liver‐on‐a‐Chip Models of Fatty Liver DiseaseHepatology 2020; 71(2): 733 doi: 10.1002/hep.31106
52
J. E. Nelson, P. Handa, B. Aouizerat, L. Wilson, L. A. Vemulakonda, M. M. Yeh, K. V. Kowdley. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphismsAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1253 doi: 10.1111/apt.13824
53
Rocío Aller, Beatriz Burgueño Gomez, Rebeca Sigüenza, Conrado Fernández-Rodríguez, Natalia Fernández, Beatriz Antolín, Miguel Dur�, María Pina, Sara Lorenzo, Concepción García, Daniel de Luis Román. Comparative study of overweight and obese patients with nonalcoholic fatty liver diseaseRevista Española de Enfermedades Digestivas 2019;  doi: 10.17235/reed.2019.5926/2018
54
Jie Wei, Yong-Zhan Zhen, Ju Cui, Fa-Lin He, Tao Shen, Gang Hu, Xiao-Hong Ren, Ya-Jun Lin. Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver diseaseArchives of Pharmacal Research 2016; 39(7): 960 doi: 10.1007/s12272-016-0770-4
55
Magdalena Losko, Jerzy Kotlinowski, Jolanta Jura. Long Noncoding RNAs in Metabolic Syndrome Related DisordersMediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/5365209
56
Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga. Investigating fibrosis and inflammation in an ex vivo NASH murine modelAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(2): G336 doi: 10.1152/ajpgi.00209.2019
57
Ye Rim Nam, Sae Bom Won, Young-Shin Chung, Chung Shil Kwak, Young Hye Kwon. Inhibitory effects ofDoenjang, Korean traditional fermented soybean paste, on oxidative stress and inflammation in adipose tissue of mice fed a high-fat dietNutrition Research and Practice 2015; 9(3): 235 doi: 10.4162/nrp.2015.9.3.235
58
Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis. Adipokines in Liver CirrhosisInternational Journal of Molecular Sciences 2017; 18(7): 1392 doi: 10.3390/ijms18071392
59
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
60
Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model ratsJournal of Pharmacy and Pharmacology 2018; 70(3): 383 doi: 10.1111/jphp.12870
61
Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos, Nelson Guardiola Meinhardt. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery PatientsObesity Surgery 2017; 27(8): 2151 doi: 10.1007/s11695-017-2627-4
62
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate HyperplasiaJournal of Korean Medical Science 2020; 35(22) doi: 10.3346/jkms.2020.35.e164
63
P. Shabani, S. Emamgholipour, M. Doosti. Advances in Clinical Chemistry 2017; 79: 1 doi: 10.1016/bs.acc.2016.10.002
64
Chan Yoon Park, Tae Yeon Kim, Ji Su Yoo, Yeonkyung Seo, Munkyong Pae, Sung Nim Han. Effects of 1,25-Dihydroxyvitamin D3 on the Inflammatory Responses of Stromal Vascular Cells and Adipocytes from Lean and Obese MiceNutrients 2020; 12(2): 364 doi: 10.3390/nu12020364
65
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signalingBiomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
66
Eunhui Seo, Yoon Sin Oh, Hee-Sook Jun. Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese MiceNutrients 2016; 8(2): 83 doi: 10.3390/nu8020083
67
Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro studyCancer Biomarkers 2017; 20(4): 411 doi: 10.3233/CBM-170157
68
Viviana Casagrande, Alessandro Mauriello, Simone Bischetti, Maria Mavilio, Massimo Federici, Rossella Menghini. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06439-x
69
Ioana Corina Bocsan, Mircea Vasile Milaciu, Raluca Maria Pop, Stefan Cristian Vesa, Lorena Ciumarnean, Daniela Maria Matei, Anca Dana Buzoianu. Cytokines Genotype-Phenotype Correlation in Nonalcoholic SteatohepatitisOxidative Medicine and Cellular Longevity 2017; 2017: 1 doi: 10.1155/2017/4297206
70
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-based novel biomarkers for nonalcoholic steatohepatitisBiomarkers in Medicine 2018; 12(5): 501 doi: 10.2217/bmm-2017-0361
71
Malleswarapu Mahesh, Munugala Bharathi, Mooli Raja Gopal Reddy, Pranati Pappu, Uday Kumar Putcha, Ayyalasomayajula Vajreswari, Shanmugam M Jeyakumar. Carrot juice ingestion attenuates high fructose-induced circulatory pro-inflammatory mediators in weanling Wistar ratsJournal of the Science of Food and Agriculture 2017; 97(5): 1582 doi: 10.1002/jsfa.7906
72
Young Hwan Jang, Dong Hyun In, Jae Kook Yang, Hyuk Jin Moon, Gyu Tae Yoon, Ah Jeong Ryu, Yeo Joo Kim, Eun Young Lee, Hyun Jin Kim, Bon Jeong Ku, Jae Min Lee, Kang Seo Park, In Suk Lee, Jong Min Lee, Dong Mee Lim, Keun Yong Park, Sang Jin Kim. The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective StudyThe Journal of Korean Diabetes 2015; 16(4): 303 doi: 10.4093/jkd.2015.16.4.303
73
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
74
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
75
Carmelo Luci, Elodie Vieira, Thibaut Perchet, Philippe Gual, Rachel Golub. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver DiseaseFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01192
76
Wen Liu, Fuxiang Bai, Hongxing Wang, Yan Liang, Xianhong Du, Cui Liu, Dejian Cai, Jiali Peng, Guangming Zhong, Xiaohong Liang, Chunhong Ma, Lifen Gao. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in MacrophagesThe Journal of Immunology 2019; 203(4): 990 doi: 10.4049/jimmunol.1900117
77
Monica Dinu, Anne Whittaker, Giuditta Pagliai, Ilaria Giangrandi, Barbara Colombini, Anna Maria Gori, Claudia Fiorillo, Matteo Becatti, Alessandro Casini, Stefano Benedettelli, Francesco Sofi. A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical TrialJournal of the American College of Nutrition 2018; 37(6): 508 doi: 10.1080/07315724.2018.1445047
78
Gopanandan Parthasarathy, Xavier Revelo, Harmeet Malhi. Pathogenesis of Nonalcoholic Steatohepatitis: An OverviewHepatology Communications 2020; 4(4): 478 doi: 10.1002/hep4.1479
79
Shunqin Wang, Jingsong Liu, Junfeng Zhang, Jiancheng Lin, Shuyu Yang, Jiangwu Yao, Minquan Du. Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitisBrazilian Oral Research 2017; 31(0) doi: 10.1590/1807-3107bor-2017.vol31.0090
80
Jaqueline Pereira Lana, Laís Bhering Martins, Marina Chaves de Oliveira, Zélia Menezes-Garcia, Letícia Tamie Pavia Yamada, Leda Quercia Vieira, Mauro Martins Teixeira, Adaliene Versiani Matos Ferreira. TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditionsApplied Physiology, Nutrition, and Metabolism 2016; 41(12): 1295 doi: 10.1139/apnm-2016-0265
81
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
82
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_37-1
83
Li Xue, Xiaolan Lu, Juntao He, Ting Zhang, Xiaokang Wu, Yanping Zhang, Ningning Wang, Zhe An, Jiru Xu, Yan Geng. Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat modelPathology - Research and Practice 2018; 214(11): 1778 doi: 10.1016/j.prp.2018.08.016
84
Vera Lede, Andrej Meusel, Antje Garten, Yulia Popkova, Melanie Penke, Christin Franke, Albert Ricken, Angela Schulz, Wieland Kiess, Daniel Huster, Torsten Schöneberg, Jürgen Schiller, Yanqiao Zhang. Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptorPLOS ONE 2017; 12(2): e0172000 doi: 10.1371/journal.pone.0172000
85
Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and CancerRecent Results in Cancer Research 2016; 208: 177 doi: 10.1007/978-3-319-42542-9_10
86
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
87
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7653689
88
Xu Zhang, Xuetao Ji, Qian Wang, John Zhong Li. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)Protein & Cell 2018; 9(2): 164 doi: 10.1007/s13238-017-0436-0
89
Jari E. Kaikkonen, Petri Kresanov, Markku Ahotupa, Antti Jula, Vera Mikkilä, Jorma S. A. Viikari, Markus Juonala, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Antti J. Kangas, Pasi Soininen, Mika Ala-Korpela, Olli T. Raitakari. Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns StudyFree Radical Research 2016; 50(4): 396 doi: 10.3109/10715762.2015.1133906
90
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver DiseasesJournal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
91
Johannes Sollner. Vaccine DesignMethods in Molecular Biology 2016; 1403: 107 doi: 10.1007/978-1-4939-3387-7_5
92
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70721
93
С. А. Павловський. The effect of complex treatment of patients with non-alcoholic steatohepatitis in combination with type 2 diabetes on the course of the inflammatory process: adiponectin and proinflammatory cytokinesFamily Medicine 2018; 0(3): 53 doi: 10.30841/2307-5112.3.2018.146359
94
Veeravich Jaruvongvanich, Anawin Sanguankeo, Tanawan Riangwiwat, Sikarin Upala. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisAnnals of Hepatology 2017; 16(3): 382 doi: 10.5604/01.3001.0009.8593
95
Dongxu Wang, Qiang Gao, Taotao Wang, Zhipeng Kan, Xin Li, Lizhen Hu, Chuan-yi Peng, Frank Qian, Yijun Wang, Daniel Granato. Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activationFood Research International 2020; 127: 108628 doi: 10.1016/j.foodres.2019.108628
96
Kui Peng, Lin Lin, Zhengyi Wang, Lin Ding, Ya Huang, Po Wang, Yu Xu, Jieli Lu, Min Xu, Yufang Bi, Weiqing Wang, Yuhong Chen, Guang Ning. Short sleep duration and longer daytime napping are associated with non-alcoholic fatty liver disease in Chinese adultsJournal of Diabetes 2017; 9(9): 827 doi: 10.1111/1753-0407.12489
97
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering stormAIDS 2019; 33(7): 1105 doi: 10.1097/QAD.0000000000002161
98
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanismsProceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
99
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic SteatohepatitisInflammation 2019; 42(3): 1056 doi: 10.1007/s10753-019-00967-6
100
Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Anna Kasprzyk-Pawelec, Shreyas Gadre, Erika Parasido, Olga Catalina-Rodriguez, Patricia Foley, Giuseppe Giaccone, Amrita Cheema, Bhaskar Kallakury, Chris Albanese, Chunling Yi, Maria Laura Avantaggiati. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASHCell Death & Differentiation 2020; 27(7): 2143 doi: 10.1038/s41418-020-0491-6
101
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver diseasePLOS ONE 2020; 15(2): e0219412 doi: 10.1371/journal.pone.0219412
102
Qian Wang, Dehai Li, Jing Zhu, Mingyue Zhang, Hua Zhang, Guangchao Cao, Leqing Zhu, Qiping Shi, Jianlei Hao, Qiong Wen, Zonghua Liu, Hengwen Yang, Zhinan Yin. Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLDFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00846
103
Mohamed M.A. Hussein, Hussein I. El-Belbasi, Mohamed A. Morsy, Islam M. Saadeldin, Ghedeir M. Alshammari. The synergistic effect of fenretinide and metformin to achieve a decrease in insulin resistance and inflammatory mediators: an in vivo studyAll Life 2020; 13(1): 108 doi: 10.1080/26895293.2020.1732483
104
Nadia Panera, Barbara Barbaro, Claudia Della Corte, Antonella Mosca, Valerio Nobili, Anna Alisi. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver diseaseNutrition Research 2018; 58: 1 doi: 10.1016/j.nutres.2018.05.002
105
M Pallavi, MM Suchitra, P.V.L.N Srinivasa Rao. Role of adipokines in the pathogenesis of nonalcoholic fatty liver diseaseJournal of Clinical and Scientific Research 2015; 4(1): 31 doi: 10.15380/2277-5706.JCSR.14.072
106
Kun Tang, Fei Wang, Yi Zeng, XueMeng Chen, XiaoLe Xu. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient miceEuropean Journal of Pharmacology 2018; 830: 76 doi: 10.1016/j.ejphar.2018.04.026
107
Wen-Chung Huang, Po-Chen Liao, Chun-Hsun Huang, Sindy Hu, Shih-Chun Huang, Shu-Ju Wu. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cellsBiomedicine & Pharmacotherapy 2017; 91: 78 doi: 10.1016/j.biopha.2017.04.051
108
Lauren Barron, Cathleen Courtney, James Bao, Emily Onufer, Roheena Z. Panni, Bola Aladegbami, Brad W. Warner. Intestinal resection-associated metabolic syndromeJournal of Pediatric Surgery 2018; 53(6): 1142 doi: 10.1016/j.jpedsurg.2018.02.077
109
Peter Müller, Marie Messmer, Monika Bayer, Josef M. Pfeilschifter, Edith Hintermann, Urs Christen. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse modelJournal of Autoimmunity 2016; 69: 51 doi: 10.1016/j.jaut.2016.02.007
110
Min-Gyung Kang, Hee Jae Lee, Jae-Young Cho, Kanghwa Kim, Soo Jin Yang, Doman Kim. Anti-inflammatory effects of sucrose-derived oligosaccharides produced by a constitutive mutant L. mesenteroides B-512FMCM dextransucrase in high fat diet-fed miceBiochemical and Biophysical Research Communications 2016; 477(3): 350 doi: 10.1016/j.bbrc.2016.06.102
111
Hon-Jhe Chen, Hao-Yu Yang, Kuang-Chieh Hsueh, Cheng-Che Shen, Ru-Yi Chen, Hsien-Chung Yu, Tzu-Lin Wang. Increased risk of osteoporosis in patients with nonalcoholic fatty liver diseaseMedicine 2018; 97(42): e12835 doi: 10.1097/MD.0000000000012835
112
F. Hérault, C. Duby, E. Baéza, C. Diot. Adipogenic genes expression in relation to hepatic steatosis in the liver of two duck speciesanimal 2018; 12(12): 2571 doi: 10.1017/S1751731118000897
113
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
114
Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky. Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver diseaseClinical and Molecular Hepatology 2020; 26(2): 216 doi: 10.3350/cmh.2019.0074
115
Lili Chen, Xiaolong Zhao, Guangjun Liang, Jiuru Sun, Zhifeng Lin, Renming Hu, Peili Chen, Zhaoyun Zhang, Linuo Zhou, Yiming Li. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitisNutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0208-0
116
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver DiseaseAdvances in Nutrition 2020;  doi: 10.1093/advances/nmaa106
117
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Seyed Ali Malek-Hosseini. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitisUnited European Gastroenterology Journal 2018; 6(1): 97 doi: 10.1177/2050640617707863
118
Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver DiseaseGenes 2019; 10(12): 966 doi: 10.3390/genes10120966
119
Alice Yuxin Wang, Jasbir Dhaliwal, Marialena Mouzaki. Lean non-alcoholic fatty liver diseaseClinical Nutrition 2019; 38(3): 975 doi: 10.1016/j.clnu.2018.08.008
120
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Adipokines in nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1062 doi: 10.1016/j.metabol.2015.11.006
121
Ana Elenka Ortíz Reyes, C. Marissa Calderón Torres. INCREMENTO DE LA EXPRESIÓN DE TLR4 Y EFECTO ANTIOXIDANTE DEL ÁCIDO ACETILSALICÍLICO EN CONEJOS CON DIETA ALTA EN GRASASRESPYN Revista de Salud Pública y Nutrición 2017; 16(2): 1 doi: 10.29105/respyn16.2-1
122
Maja Cigrovski Berkovic, Lucija Virovic-Jukic, Ines Bilic-Curcic, Anna Mrzljak. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and managementWorld Journal of Gastroenterology 2020; 26(21): 2740-2757 doi: 10.3748/wjg.v26.i21.2740
123
Pavel Kraml. Lipid-lowering therapy in selected specific groups of patientsMedicína pro praxi 2020; 17(3): 151 doi: 10.36290/med.2020.029
124
Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De-Xing Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat DietMolecules 2018; 23(12): 3213 doi: 10.3390/molecules23123213
125
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2020; 21(11): 4189 doi: 10.3390/ijms21114189
126
Youzhao Jiang, Liu Chen, Hui Wang, Bao Narisi, Bing Chen. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stressJournal of Ethnopharmacology 2015; 176: 499 doi: 10.1016/j.jep.2015.11.019
127
Milton Packer. Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver DiseaseThe American Journal of Medicine 2020; 133(2): 170 doi: 10.1016/j.amjmed.2019.09.002
128
K Konepudi, D Singh, K Podili, R Boparai, M Bishnoi. Food Microbiology2015; : 157 doi: 10.1201/b19874-10
129
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 755 doi: 10.1007/978-94-007-7675-3_37
130
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advancesThe Journal of Pathology 2017; 241(1): 36 doi: 10.1002/path.4829
131
Magdalena Świderska, Mateusz Maciejczyk, Anna Zalewska, Joanna Pogorzelska, Robert Flisiak, Adrian Chabowski. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patientsFree Radical Research 2019; 53(8): 841 doi: 10.1080/10715762.2019.1635691
132
S. A. Pavlovskyi. EVALUATION OF CONTENT OF CITOKINS IN PATIENTS� BLOOD WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2 UNDER THE INFLUENCE OF COMBINED SUCTIONAL THERAPYBulletin of Problems Biology and Medicine 2018; (144): 170 doi: 10.29254/2077-4214-2018-1-2-143-170-175
133
J.E. Davis, J. Cain, C. Small, D.B. Hales. Therapeutic effect of flax-based diets on fatty liver in aged laying hensPoultry Science 2016; 95(11): 2624 doi: 10.3382/ps/pew160
134
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese ChildrenCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3870454
135
Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant featuresPathology International 2018; 68(1): 12 doi: 10.1111/pin.12612
136
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
137
Song Wang, Jian Wang, Yajing Liu, Hui Li, Qiao Wang, Zhiwei Huang, Wenbin Liu, Ping Shi. Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in MiceBiological Trace Element Research 2019; 187(1): 192 doi: 10.1007/s12011-018-1368-0
138
A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imagingBritish Journal of Biomedical Science 2019; 76(2): 70 doi: 10.1080/09674845.2019.1571555
139
Mooli Raja Gopal Reddy, Malleswarapu Mahesh, Munikumar Manne, Uday Kumar Putcha, Shanmugam M. Jeyakumar. Vitamin A and its metabolic pathway play a determinant role in high‐fructose‐induced triglyceride accumulation of the visceral adipose depot of male Wistar ratsCell Biochemistry and Function 2019; 37(8): 578 doi: 10.1002/cbf.3434